Clairo

Executive Director/ Vice President Sales- Cardiac

United States

Clairo Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Devices, Healthcare, Cardiology, Medical EquipmentIndustries

Requirements

Candidates should possess a Bachelor’s degree or equivalent experience, with 7-10 years of sales experience within the pharmaceutical, health, life science, or related regulated industry, and experience selling capital equipment and services, pharmaceutical and biotech products, technology and related services, or similar. They should have proven capability to positively influence high-value customers resulting in desired business outcomes, demonstrated ability to develop collaborative relationships with key thought leaders and high-value customers, and excellent communication skills, including verbal and written proficiency, as well as the ability to communicate effectively with medical professionals.

Responsibilities

The Executive Director/Vice President Sales will be responsible for maximizing profit by achieving sales revenue targets and growing market share within a specified territory, developing and executing strategic sales programs, leading and managing individual contributors to drive business success, supporting the expansion of Clario’s business, working closely with internal teams to enhance product offerings and optimize sales strategies, participating in sales, product management, and strategic initiative meetings, negotiating and contracting new business, managing business development, driving continuous improvement initiatives, mentoring and coaching team members, and completing timely and accurate administrative deliverables such as sales reports and expense reports.

Skills

Sales Strategy
Business Development
Account Management
Forecasting
Salesforce
Negotiation
Market Analysis
Team Leadership
Communication
Strategic Planning

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI